Similar articles

• The use of amphetamine induced stereotyped behaviour as a model for the experimental evaluation of antiparkinson agents.

  Costall B, Naylor RJ, Wright T. Costall B, et al. Arzneimittelforschung. 1972 Jul;22(7):1178-83. Arzneimittelforschung. 1972. PMID: 4404343 No abstract available.
• Pharmacology of the mechanism of certain effects of reserpine in the rat.

  Fischer E, Heller B. Fischer E, et al. Nature. 1967 Dec 23;216(5121):1221-2. doi: 10.1038/2161221a0. Nature. 1967. PMID: 4383823 No abstract available.
• Inhibitory effects of various agents on the activity of tropinesterases.

  Otorii T. Otorii T. Acta Med Biol (Niigata). 1969 Sep;17(2):177-91. Acta Med Biol (Niigata). 1969. PMID: 4390765 No abstract available.
• [Recent advances and pharmacological basis of the medical treatment of Parkinson's syndrome].

  Shibazaki H. Shibazaki H. Shinkei Kenkyu No Shimpo. 1971;15(4):992-1002. Shinkei Kenkyu No Shimpo. 1971. PMID: 4400830 Review. Japanese. No abstract available.
• Pharmacology of Parkinson's disease.

  Burton K, Calne DB. Burton K, et al. Neurol Clin. 1984 Aug;2(3):461-72. Neurol Clin. 1984. PMID: 6152482 Review.